SCHEMBL13428193

SCHEMBL13428193

c1ccc(-c2cc3ccccc3cc2-c2c3cc(N4c5ccccc5CCc5ccccc54)ccc3c(-c3cccc4ccccc34)c3cc(N4c5ccccc5CCc5ccccc54)ccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.33
POLB P06746 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
LMNA P02545 2/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
CYP3A4 P08684 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.31
EGFR P00533 1/20 0.30
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30
MPI P34949 1/20 0.30
KMT2A Q03164 1/20 0.30
HTR1A P08908 1/20 0.30
DRD2 P14416 1/20 0.30
HTR7 P34969 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13427045 0.93 PDE6D (0.33) PDE6DPOLBKDM4EALDH1A1HPGD
SCHEMBL13428191 0.93 PDE6D (0.34) PDE6DPOLBCYP1A2CYP2C9CYP2C19
SCHEMBL13428109 0.93 LMNA (0.35) PDE6DCYP1A2CYP2C9CYP2C19LMNA
SCHEMBL13008867 0.92 PDE6D (0.34) PDE6DPOLBCYP1A2CYP2C9CYP2C19
SCHEMBL13008826 0.92 PDE6D (0.34) PDE6DPOLBCYP1A2CYP2C9CYP2C19
SCHEMBL13009166 0.91 POLB (0.38) POLBCYP1A2CYP2C9CYP2C19LMNA
SCHEMBL13428173 0.90 PDE6D (0.38) PDE6DPOLBCYP1A2CYP2C9CYP2C19
SCHEMBL13428147 0.89 PDE6D (0.36) PDE6DPOLBCYP1A2CYP2C9CYP2C19
SCHEMBL13428185 0.89 HDAC8 (0.35) PDE6DPOLBCYP1A2CYP2C9CYP2C19
SCHEMBL13008844 0.88 PDE6D (0.36) PDE6DPOLBCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A PDE6D 3559/4885POLB 913/4885CYP1A2 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.